Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type  2 diabetes and osteopenia/osteoporosis

ConclusionsSwitching to Dmab from BP or SERM is beneficial to prevent osteoporosis progression in postmenopausal patients with type  2 diabetes mellitus patients.

Source: Journal of Diabetes Investigation - December 13, 2020 Category: Endocrinology Authors: Arina Miyoshi, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi, Hideaki Miyoshi Tags: Original Article Source Type: research